169 related articles for article (PubMed ID: 12617187)
1. Large-cell medulloblastoma with arrestin-like protein expression.
Vincent S; Mirshari M; Nicolas C; Adenis C; Dhellemmes P; Soto Ares G; Maurage CA; Baranzelli MC; Giangaspero F; Ruchoux MM
Clin Neuropathol; 2003; 22(1):1-9. PubMed ID: 12617187
[TBL] [Abstract][Full Text] [Related]
2. Cytogenetic evaluation of isochromosome 17q in posterior fossa tumors of children and correlation with clinical outcome in medulloblastoma. Detection of a novel chromosomal abnormality.
DeChiara C; Borghese A; Fiorillo A; Genesio R; Conti A; D'Amore R; Pettinato G; Varone A; Maggi G
Childs Nerv Syst; 2002 Aug; 18(8):380-4. PubMed ID: 12192498
[TBL] [Abstract][Full Text] [Related]
3. Glioblastoma occurring at the site of a previous medulloblastoma following a 5-year remission period.
Martin SE; Brat DJ; Vance GH; Stohler R; Choi H; Douglas-Akinwande AC; Hattab EM
Neuropathology; 2012 Oct; 32(5):543-50. PubMed ID: 22151431
[TBL] [Abstract][Full Text] [Related]
4. Large-cell medulloblastomas. A distinct variant with highly aggressive behavior.
Giangaspero F; Rigobello L; Badiali M; Loda M; Andreini L; Basso G; Zorzi F; Montaldi A
Am J Surg Pathol; 1992 Jul; 16(7):687-93. PubMed ID: 1530108
[TBL] [Abstract][Full Text] [Related]
5. Radiation-induced cerebellar glioblastoma at the site of a treated medulloblastoma: case report.
Yang SY; Wang KC; Cho BK; Kim YY; Lim SY; Park SH; Kim IH; Kim SK
J Neurosurg; 2005 May; 102(4 Suppl):417-22. PubMed ID: 15926395
[TBL] [Abstract][Full Text] [Related]
6. Medulloblastoma with myogenic differentiation showing double immunopositivity for synaptophysin and myoglobin.
Kido M; Ueno M; Onodera M; Matsumoto K; Imai T; Haba R; Tamiya T; Huang CL; Sakamoto H
Pathol Int; 2009 Apr; 59(4):255-60. PubMed ID: 19351370
[TBL] [Abstract][Full Text] [Related]
7. Isochromosome 17q is a negative prognostic factor in poor-risk childhood medulloblastoma patients.
Pan E; Pellarin M; Holmes E; Smirnov I; Misra A; Eberhart CG; Burger PC; Biegel JA; Feuerstein BG
Clin Cancer Res; 2005 Jul; 11(13):4733-40. PubMed ID: 16000568
[TBL] [Abstract][Full Text] [Related]
8. Concurrent gain of 17q and the MYC oncogene in a medullomyoblastoma.
Lindberg E; Persson A; Øra I; Mertens F; Englund E; Gisselsson D
Neuropathology; 2007 Dec; 27(6):556-60. PubMed ID: 18021376
[TBL] [Abstract][Full Text] [Related]
9. Classic and desmoplastic medulloblastoma: complete case reports and characterizations of two new cell lines.
Holthouse DJ; Dallas PB; Ford J; Fabian V; Murch AR; Watson M; Wong G; Bertram C; Egli S; Baker DL; Kees UR
Neuropathology; 2009 Aug; 29(4):398-409. PubMed ID: 19077040
[TBL] [Abstract][Full Text] [Related]
10. "Primary" leptomeningeal medulloblastoma.
Mehta RI; Cutler AR; Lasky JL; Yong WH; Lerner JT; Hirota BK; Salamon N; Mathern GW; Vinters HV
Hum Pathol; 2009 Nov; 40(11):1661-5. PubMed ID: 19695677
[TBL] [Abstract][Full Text] [Related]
11. Isochromosome 17q, MYC amplification and large cell/anaplastic phenotype in a case of medullomyoblastoma with extracranial metastases.
Wright KD; von der Embse K; Coleman J; Patay Z; Ellison DW; Gajjar A
Pediatr Blood Cancer; 2012 Sep; 59(3):561-4. PubMed ID: 22147345
[TBL] [Abstract][Full Text] [Related]
12. Cerebellopontine angle medulloblastoma.
Nyanaveelan M; Azmi A; Saffari M; Banu SK; Suryati MY; Jeyaledchumy M
Med J Malaysia; 2007 Jun; 62(2):173-4. PubMed ID: 18705459
[TBL] [Abstract][Full Text] [Related]
13. Role of LIM and SH3 protein 1 (LASP1) in the metastatic dissemination of medulloblastoma.
Traenka C; Remke M; Korshunov A; Bender S; Hielscher T; Northcott PA; Witt H; Ryzhova M; Felsberg J; Benner A; Riester S; Scheurlen W; Grunewald TG; von Deimling A; Kulozik AE; Reifenberger G; Taylor MD; Lichter P; Butt E; Pfister SM
Cancer Res; 2010 Oct; 70(20):8003-14. PubMed ID: 20924110
[TBL] [Abstract][Full Text] [Related]
14. Genomics identifies medulloblastoma subgroups that are enriched for specific genetic alterations.
Thompson MC; Fuller C; Hogg TL; Dalton J; Finkelstein D; Lau CC; Chintagumpala M; Adesina A; Ashley DM; Kellie SJ; Taylor MD; Curran T; Gajjar A; Gilbertson RJ
J Clin Oncol; 2006 Apr; 24(12):1924-31. PubMed ID: 16567768
[TBL] [Abstract][Full Text] [Related]
15. Identification of a novel homozygous deletion region at 6q23.1 in medulloblastomas using high-resolution array comparative genomic hybridization analysis.
Hui AB; Takano H; Lo KW; Kuo WL; Lam CN; Tong CY; Chang Q; Gray JW; Ng HK
Clin Cancer Res; 2005 Jul; 11(13):4707-16. PubMed ID: 16000565
[TBL] [Abstract][Full Text] [Related]
16. Identification and characterization of interleukin-13 receptor in human medulloblastoma and targeting these receptors with interleukin-13-pseudomonas exotoxin fusion protein.
Joshi BH; Leland P; Puri RK
Croat Med J; 2003 Aug; 44(4):455-62. PubMed ID: 12950150
[TBL] [Abstract][Full Text] [Related]
17. Medulloblastoma with multi-lineage differentiation including myogenic and melanotic elements: a case report with molecular data.
Stefanits H; Ebetsberger-Dachs G; Weis S; Haberler C
Clin Neuropathol; 2014; 33(2):122-7. PubMed ID: 24131750
[TBL] [Abstract][Full Text] [Related]
18. [Melanotic medulloblastoma. Ultrastructural and histochemical study of a case].
García-Bragado F; Cabello A; Guarch R; Ruiz de Azúa Y; Ezpeleta I
Arch Neurobiol (Madr); 1990; 53(1):8-12. PubMed ID: 2203326
[TBL] [Abstract][Full Text] [Related]
19. Clinical, histopathologic, and molecular markers of prognosis: toward a new disease risk stratification system for medulloblastoma.
Gajjar A; Hernan R; Kocak M; Fuller C; Lee Y; McKinnon PJ; Wallace D; Lau C; Chintagumpala M; Ashley DM; Kellie SJ; Kun L; Gilbertson RJ
J Clin Oncol; 2004 Mar; 22(6):984-93. PubMed ID: 14970185
[TBL] [Abstract][Full Text] [Related]
20. Medulloblastoma: tumorigenesis, current clinical paradigm, and efforts to improve risk stratification.
Polkinghorn WR; Tarbell NJ
Nat Clin Pract Oncol; 2007 May; 4(5):295-304. PubMed ID: 17464337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
